Диссертация (1140223), страница 29
Текст из файла (страница 29)
Ludmer P.L., Selwyn A.P., Shook T.L., Wayne R.R., Mudge G.H., Alexander R.W.,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronaryarteries // N Engl J Med. 1986; 315: 1046–1051.120. Lui J., Trevisan M., Menotti A. Syndrome X: prevalence in large population study //NMCD. 1997; 7:70-76.121. Lumeng C.N. and Saltiel A.R. Inflammatory links between obesity and metabolicdisease // The Journal of Clinical Investigation.
2011, 121(6):2111–2117.122. Margetic S., Gazzola C., Pegg1 G.G. and Hill R.A. Leptin: a review of its peripheralactions and interactions // International Journal of Obesity. 2002; 26:1407–1433.123. Marra F. Leptin and liver fibrosis: a matter of fat // Gastroenterology. 2002;122:1529-1532.165124. Marsh A.J., Fontes M.A.P., Killinger S., Pawlak D.B., Polson J.W. and DampneyR.A.L. Cardiovascular responses evoked by leptin acting on neurons in the ventromedialand dorsomedial hypothalamus // Hypertension. 2003; 42(4):488–493.125.
Martins A.R., Nachbar R.T., Gorjao R., Vinolo M.A., Festuccia W.T., LambertucciR.H. et al. Mechanisms underlying skeletal muscle insulin resistance induced by fattyacids: importance of the mitochondrial function // Lipids in Health and Disease. 2012;11, article 30.126. Mawatari S, Uto H, Tsubouchi H. Chronic liver disease and arteriosclerosis //Nippon Rinsho. 2011; 69(1):153–157.127. Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H., et al.Human epicardial adipose tissue is a source of inflammatory mediators // Circulation.2003; 108:2460-2466.128.
McKechnie R., Mosca L. Physical activity and coronary heart disease: preventionand effect on risk factors // Cardiol Rev. 2003; 11:21–25.129. Morishima N., Nakanishi K., Xakenouchi H., Shibata X and Yasuhiko Y. Anendoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome cindependent activation of caspase-9 by caspase-12 // J Biol Chem.
2002; 227:3428734294.130. Mottin C.C., Moretto M., Padoin A.V., Swarowsky A.M., Toneto M.G., Glock L.,et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obesepatients // Obes Surg. 2004; 14:635–637.131. Murata M., Thanan R., Kawanishi N. Ma and S. Role of nitrative and oxidativeDNA damage in inflammation-related carcinogenesis // Journal of Biomedicine andBiotechnology.
2012, Article ID 623019.132. Musso G., Gambino R., Cassader M. Non-alcoholic fatty liver disease frompathogenesis to management: an update // Obesity Reviews. 2010; 11(6):430–445.133. Nakahara S., Hogan V., Inohara H., Raz A. et al. Importin-mediated nucleartranslocation of galectin-3 // J Biol Chem. 2006; 281:39649-39659.134.
Natale F., Tedesco M.A., Mocerino R., de Simone V., Di Marco G.M., Aronne L. etal. Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness166reflects, better than waist circumference, carotid arterial stiffness in a large population ofhypertensives // Eur J Echocardiogr. 2009; 10(4):549-555.135. Neil C. Henderson at all. Galectin-3 regulates myofibroblast activation and hepaticfibrosis // Proc Natl Acad Sci USA. 2006; 103(13):5060–5065.136.
Newsholme P., Haber E.P., Hirabara S.M., Rebelato ELO, Procopio J., Morgan D.,et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and nonmitochondrial ROS production and activity // Journal of Physiology. 2007; 583(1):9–24.137. Ogawa E., Furusyo N., Toyoda K. Takeoka H., Maeda S., Hayashi J. Thelongitudinal quantitative assessment by transient elastography of chronic hepatitis Cpatients treated with with pegylated interferon alpha-2d and ribavirin // Antiviral Res.2009; 83(2):127–34.138.
Okamoto M., Ohara-Imaizumi M., Kubota N., Hashimoto, S., Eto, K., Kanno, T., etal. Adiponectin induced secretion in vitro and in vivo at a low glucose concentration //Diabetologia. 2008; 51:516-519.139. Okere I.C., Chandler M.P., McElfresh T.A., Rennison J.H., Sharov V., SabbahH.N., et al. Differential effects of saturated and unsaturated fatty acid diets oncardiomyocyte apoptosis, adipose distribution, serum leptin // Am J Physiol Heart CircPhysiol. 2006; 291:38–44.140. Olivetti G., Abbi R., Quaini F. Kajstura J, Cheng W, Nitahara JA, et al. Apoptosisin the failing human heart // New Engl.
J. Med. 1997; 336:1131–1141.141. Park E.M., Choi J-H., Shin I-S., Yun K.H., Yoo N.J., yu Oh S.K., et al.Echocardiographic Epicardial Fat Thickness on Short Term Prognosis in Patients WithAcute Coronary Syndrome // Journal of Cardiovascular Ultrasound. 2008;16(2):42-47.142. Pasarin M., Abraldes J.G., Rodriguez-Vilarrupla A., La Mura V., Garcia-Pagan J.C.,et al.
Insulin resistance and liver microcirculation in a rat model of early NAFLD // JHepatol. 2011, 55:1095–1102.143. Paschos P., Paletas K. Non alcoholic fatty liver disease and metabolic syndrome //Hippoktatia. 2009, 13(1):9-19.144. Perseghin G, EASL Congress abstracts, 2009, p.36.167145. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B. and Rimm E.B.Plasma adiponectin levels and risk of myocardial infarction in Men // Journal of theAmerican Medical Association. 2004; 291(14):1730–1737.146.
Rajapurohitam V., Gan X.T., Kirshenbaum L.A. and Karmazyn M. The ObesityAssociated Peptide Leptin Induces Hypertrophy in Neonatal Rat Ventricular Myocytes //Circulation Research. 2003; 93:277–287.147. Reaven GM. Relationship between insulin resistance and hypertension // DiabetesCare. 1991; 4(14):33-41.148. Reaven G.M. The insulin resistance syndrome: definition and dietary approaches totreatment // Ann Rev Nut. 2005; 25:391-406.149.
Reifenberg K., Lehr H.A., Torzewski M., Steige G., Wises E., Kupper I. et al.Interferon-g induces chronic active myocarditis and cardiomyopathy in transgenic mice //Am J Pathol. 2007; 171:463-472.150. Ruan H., Miles P.D., Ladd C.M. Profiling gene transcription in vivo reveals adiposetissue as an immediate target of tumor necrosis factor-α: implications for insulinresistence // Diabetes. 2002; 51: 3176-3188.151. Rubbo H., Trostchansky A., Botti H., Batthyany C.
Interactions of nitric oxide andperoxynitrite with low-density lipoprotein // Biol Chem. 2002; 383:547-552.152. Rubinstein N., Ilarregui J.M., Toscano M.A., and Rabinovich G.A. The role ofgalectins in the initiation, amplification and resolution of the inflammatory response //Tissue Antigens. 2004; 64:1-12.153. Sara B. Fournier, Brian L.
Reger, David A. Donley, Daniel E. Bonner et al. Exercisereveals impairments in left ventricular systolic function in patients with metabolicsyndrome // Experimental Physiology. 2014; 99(1):149–163.154. Schenk S., Saberi M., Olefsky J.M. Insulin sensitivity: modulation by nutrients andinflammation // J Clin Invest. 2008, 118:2992-3002.155. Schilacci G., Pirro M., Vaudo G., Mannarino M.R., Savarese G., Pucci G.
et al.Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension// Hypertension. 2005; 45: 1978-1982.156. Shankar A., Xiao J. Positive relationship between plasma leptin level andhypertension // Hypertension. 2010; 56(4):623–628.168157. Sharma U., Rhaleb N.E., Pokharel S., Harding P., Rasoul S., Peng H. et al. Novelanti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-inducedtarget organ damage // Am J Physiol.
2008; 294:1226-1232.158. Shintani M., Nishimura H., Yonemitsu S., Masuzaki H., Ogawa Y., Hosoda K. et al.Downregulation of leptin by free fatty acids in rat adipocytes: effects of triascin C,palmitate, and 2-bromopalmitate // Metabolism. 2000; 49:326-330.159. Silaghi A., Achard V., Paulmyer-Lacroix O., Scridon T., Tassistro V., Duncea I., etal. Expression of adrenomedullin in human epicardial adipose tissue: role of coronarystatus // Am J Physiol Endocrinol Metab. 2007; 293(5):1443–1450.160. Silver D.L., Wang N., Tall A.R.
Defective HDL particle uptake in ob/obhepatocytes causes decreased recycling, degradation and selective lipid uptake //J.Clin.Invest. 2000; 105(2):151–159.161. Skulachev V.P. Mitochondria in the Programmed Death Phenomena; a Principle ofBiology: "It Is Better to Die than to be Wrong" // IUBMB Life. 2000; 49:365-373.162. Solinas G., Naugler W., Galimi F., Lee M.S., and Karin M. Saturated fatty acidsinhibit induction of insulin gene transcription by JNK-mediated phosphorylation ofinsulinreceptor substrates // Proceedings of the National Academy of Sciences of theUnited States of America. 2006; 103(44):16454–16459.163.
Steinberg D., Witztum J.L. Is the oxidative modification hypothesis relevant tohuman atherosclerosis? // Circulation. 2002; 105:2107—2111.164. Steven E., Lee Jongsoon, and Goldfine Allison B. Inflammation and InsulinResistance // Journal of Clinical Investigation. 2006, 116(7):1793-1801.165. Sutherland J.P., McKinley B., Eckel R.H. The metabolic syndrome andinflammation // Metab Syndr Relat Disord. 2004; 2:82–104.166. Targher G., Bertolini L., Scala L., Zoppini G., Zenari L., Falezza G.
et al. Decreasedplasma adiponectin concentrations are closely associated with non-alcoholic hepaticsteatosis in obese individuals // Clin Endocrinol. 2004; 61:700-703.167. Targher G., Day C.P., and Bonora E. Risk of Cardiovascular Disease in Patientswith Nonalcoholic Fatty Liver Disease // The New England Journal of Medicine. 2010;363(14):1341-1350.169168. Tarquini R., Lazzeri C., Boddi M. Non–alcoholic fatty liver disease: a newchallenge for cardiologists // G Ital Cardiol (Rome).
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
